Calcium channel blockers and the prevention of atherosclerosis

Antonio Gotto

doi:10.1093/ajh/3.12.342S

Calcium channel blockers and the prevention of atherosclerosis

Antonio Gotto

Research output: Contribution to journal › Article

9 Scopus citations

Abstract

The presence of calcium in atherosclerotic plaques has long been recognized; however, its role in plaque formation is not yet fully elucidated. Over the past decade, investigators have studied the effects of various calcium channel blockers on atherogenesis in animals and have demonstrated that such agents may retard plaque formation. Recent studies in patients with coronary artery disease have demonstrated that the calcium channel blocker nifedipine may impede or prevent the development of atherosclerotic plaques in humans as well.

Original language	English (US)
Pages (from-to)	342S-346S
Journal	American Journal of Hypertension
Volume	3
Issue number	12
DOIs	https://doi.org/10.1093/ajh/3.12.342S
State	Published - Jan 1 1990

Keywords

Atherosclerosis
Calcium
Nifedipine

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1093/ajh/3.12.342S

Fingerprint Dive into the research topics of 'Calcium channel blockers and the prevention of atherosclerosis'. Together they form a unique fingerprint.

Cite this

@article{1213bc9a0e1640658c616c761ee9045c,

title = "Calcium channel blockers and the prevention of atherosclerosis",

abstract = "The presence of calcium in atherosclerotic plaques has long been recognized; however, its role in plaque formation is not yet fully elucidated. Over the past decade, investigators have studied the effects of various calcium channel blockers on atherogenesis in animals and have demonstrated that such agents may retard plaque formation. Recent studies in patients with coronary artery disease have demonstrated that the calcium channel blocker nifedipine may impede or prevent the development of atherosclerotic plaques in humans as well.",

keywords = "Atherosclerosis, Calcium, Nifedipine",

author = "Antonio Gotto",

year = "1990",

month = jan,

day = "1",

doi = "10.1093/ajh/3.12.342S",

language = "English (US)",

volume = "3",

pages = "342S--346S",

journal = "American Journal of Hypertension",

issn = "0895-7061",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Calcium channel blockers and the prevention of atherosclerosis

AU - Gotto, Antonio

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The presence of calcium in atherosclerotic plaques has long been recognized; however, its role in plaque formation is not yet fully elucidated. Over the past decade, investigators have studied the effects of various calcium channel blockers on atherogenesis in animals and have demonstrated that such agents may retard plaque formation. Recent studies in patients with coronary artery disease have demonstrated that the calcium channel blocker nifedipine may impede or prevent the development of atherosclerotic plaques in humans as well.

AB - The presence of calcium in atherosclerotic plaques has long been recognized; however, its role in plaque formation is not yet fully elucidated. Over the past decade, investigators have studied the effects of various calcium channel blockers on atherogenesis in animals and have demonstrated that such agents may retard plaque formation. Recent studies in patients with coronary artery disease have demonstrated that the calcium channel blocker nifedipine may impede or prevent the development of atherosclerotic plaques in humans as well.

KW - Atherosclerosis

KW - Calcium

KW - Nifedipine

UR - http://www.scopus.com/inward/record.url?scp=0025678548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025678548&partnerID=8YFLogxK

U2 - 10.1093/ajh/3.12.342S

DO - 10.1093/ajh/3.12.342S

M3 - Article

C2 - 2078321

AN - SCOPUS:0025678548

VL - 3

SP - 342S-346S

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 12

ER -